INVO Bioscience Enters Exclusive U.S. Licensing Agreement with Ferring Pharmaceuticals to Commercialize the Novel INVOcell(TM) System for Use in the Treatment of Infertility

Stock Information for INVO BioScience, Inc.

Loading

Please wait while we load your information from QuoteMedia.